by
Lisa Chamoff, Contributing Reporter | June 15, 2020
From the May 2020 issue of HealthCare Business News magazine
The company also continues to work with its clinical partners to share research on use of its uEXPLORER. Studies underway at facilities such as UC Davis and overseas have looked at performing higher-resolution scans while keeping scan times the same. The company is currently manufacturing the first systems at its Houston facility and has also engaged in a strategic partnership with BAMF Health, the first organization in the United States to purchase United Imaging's uEXPLORER and uPMR 790 PET/MR for clinical use.
The company also received FDA clearance this past January for its HYPER-Iterative reconstruction technology, which Bundy said brings noise control into each iteration and allows for consistent improvement of lesion detectability and quantitative accuracy, regardless of patient type. This feature is now standard on the uMI 550 and is rolling out to the rest of the PET portfolio in the coming months.
Another technology that is aimed at future imaging and workflow improvements and that uses a deep learning approach, called HYPER DLR, is under consideration by the FDA.
Back to HCB News
